Tal Danino, Ph.D.
Affiliations: | 2011 | Bioengineering | University of California, San Diego, La Jolla, CA |
Area:
Biomedical, Genetics, GeneralGoogle:
"Tal Danino"Parents
Sign in to add mentor| Jeff Hasty | grad student | 2011 | UCSD | |
| (Synthetic gene oscillators and their applications.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Barra M, Danino T, Garrido D. (2020) Engineered Probiotics for Detection and Treatment of Inflammatory Intestinal Diseases. Frontiers in Bioengineering and Biotechnology. 8: 265 |
| Gurbatri CR, Lia I, Vincent R, et al. (2020) Engineered probiotics for local tumor delivery of checkpoint blockade nanobodies. Science Translational Medicine. 12 |
| Harimoto T, Singer Z, Velazquez O, et al. (2020) Abstract 6317: 3D multicellular coculture platform enables rapid engineering of tumor-homing bacteria Cancer Research. 80: 6317-6317 |
| Gurbatri C, Lia I, Vincent R, et al. (2020) Abstract 6248: Engineered probiotics for local delivery of checkpoint blockade nanobodies Cancer Research. 80: 6248-6248 |
| Chowdhury S, Castro S, Coker C, et al. (2019) Programmable bacteria induce durable tumor regression and systemic antitumor immunity. Nature Medicine |
| Harimoto T, Singer ZS, Velazquez OS, et al. (2019) Rapid screening of engineered microbial therapies in a 3D multicellular model. Proceedings of the National Academy of Sciences of the United States of America |
| Fedorec AJH, Ozdemir T, Doshi A, et al. (2019) Two New Plasmid Post-segregational Killing Mechanisms for the Implementation of Synthetic Gene Networks in Escherichia coli. Iscience |
| Ozdemir T, Fedorec AJH, Danino T, et al. (2018) Synthetic Biology and Engineered Live Biotherapeutics: Toward Increasing System Complexity. Cell Systems. 7: 5-16 |
| Chien T, Doshi A, Danino T. (2017) Advances in bacterial cancer therapies using synthetic biology. Current Opinion in Systems Biology. 5: 1-8 |
| Geller LT, Barzily-Rokni M, Danino T, et al. (2017) Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine. Science (New York, N.Y.). 357: 1156-1160 |